Analyst Price Targets — UHS
Latest News for UHS
Universal Health Services is deeply undervalued at 7.4x 2026E NTM earnings despite robust free cash flow and pricing power. Structural tailwinds in behavioral health, high ROIIC (15.5%), and disciplined share buybacks drive 12.1% FCFE-per-share CAGR through 2030E. Scenario analysis shows downside protection at current prices, with a base case fair value of $280.99 and a recommended accumulation limit of $217.
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock?
KING OF PRUSSIA, Pa., Aug. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the following conferences: September 8, 2026, at 8:45am ET at the Wells Fargo Healthcare Conference September 14, 2026, at 8:30am ET at the Morgan Stanley Global Healthcare Conference September 15, 2026, at 10:15am ET at the Baird Global Healthcare Conference A live audio webcast of the…
UHS' 21% YTD slide has cheapened its valuation, but weaker volumes, ACA pressure and lower growth forecasts keep risks elevated.
Universal Health's $835M Talkspace acquisition expands virtual behavioral health, adding 6,000 providers and new growth opportunities.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for UHS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.